PATH (UiPath Inc., NYSE) at $15.10 intraday 15 Jan 2026: AI automation growth vs. insider sales
UiPath Inc. (PATH) trades USD 15.095 intraday on the NYSE on 15 Jan 2026 after a -5.48% session move. PATH stock is reacting to recent insider sales and renewed investor focus on AI-led automation demand. We review key financials, technical signals, analyst price targets and our model forecast to frame a clear short-term and medium-term outlook for PATH stock on this trading day.
PATH stock intraday snapshot
UiPath (PATH) opened at USD 15.39 and is trading between USD 15.03 and USD 15.45 today on the NYSE. Volume is 15,115,143 versus an average of 24,053,340, giving a relative volume of 1.21, which shows above-average trading interest. The one-day change is -0.88 USD (-5.48%), and the 52-week range is USD 9.38 to USD 19.84.
Earnings, valuation and financial metrics
UiPath reported trailing EPS of 0.42 and trades at a trailing PE of 36.58, reflecting premium growth expectations for AI automation. Revenue per share is 2.88 and free cash flow per share is 0.58, with a healthy current ratio of 2.54. Market capitalization stands near USD 8.22 billion, and debt is minimal with debt-to-equity of 0.04, supporting balance-sheet resilience.
PATH earnings drivers and recent news
Management highlighted ARR near USD 1.8 billion at presentations and emphasized AI-native automation as the growth engine, per a Needham conference transcript source. Insider sales by CEO Daniel Dines in early January pressured the stock and were reported in MarketBeat’s coverage of volume and price moves source.
Technicals, liquidity and sector context
Technical indicators show neutral momentum: RSI 48.95, MACD histogram slightly negative, and ADX at 18.02 indicating no strong trend. Bollinger bands place the middle at USD 16.63 and the lower band at USD 15.35, so current price sits near the lower band. PATH sits in the Technology sector and Software – Infrastructure industry, where peers are testing growth valuations while customers adopt AI automation.
Meyka AI grade and analyst consensus
Meyka AI rates PATH with a score out of 100: 75.20 (B+) — BUY. This grade factors in S&P 500 comparison, sector and industry metrics, financial growth, key ratios, analyst consensus and forecasts. Wall Street targets range from USD 13.00 to USD 19.00, with a MarketBeat consensus near USD 16.00, reflecting mixed Hold/Buy views.
PATH forecast, price targets and risks
Meyka AI’s forecast model projects a 12-month fair value near USD 16.65, implying an upside of 10.30% versus current price USD 15.095; forecasts are model-based projections and not guarantees. Upside catalysts include broader AI adoption and ARR expansion; downside risks include insider selling sentiment, slower enterprise spend, and stretched near-term multiples (price-to-sales 5.32, price-to-book 4.32).
Final Thoughts
Key takeaways for PATH stock: UiPath trades at USD 15.095 intraday on 15 Jan 2026 amid higher-than-average volume and a -5.48% session move tied to insider selling and headline risk. Fundamentals show improving profitability with EPS 0.42 and strong cash metrics, but the stock carries a premium multiple (PE 36.58) that requires continued revenue and ARR expansion to justify valuation. Meyka AI rates PATH with a 75.20 (B+) — BUY, and our model projects a USD 16.65 12-month forecast, implying ~10.30% upside from current levels; forecasts are model-based projections and not guarantees. Short-term traders should monitor liquidity and technicals (RSI 48.95, Bollinger lower USD 15.35) while longer-term investors should weigh AI-driven growth versus valuation and insider activity. For real-time alerts and expanded data on PATH stock, visit our PATH coverage page at https://meyka.ai/stocks/PATH and follow upcoming earnings on 11 Mar 2026 for updated guidance and ARR metrics.
FAQs
What is driving PATH stock today?
PATH stock moved lower intraday on 15 Jan 2026 after CEO insider sales and increased trading volume. Investors are weighing near-term sentiment against UiPath’s AI automation revenue growth and upcoming earnings on 11 Mar 2026.
What price targets exist for PATH stock?
Analyst targets range from USD 13.00 to USD 19.00, with MarketBeat consensus near USD 16.00. Meyka AI’s 12-month model forecast is USD 16.65, implying about 10.30% upside from USD 15.095.
How does Meyka AI rate PATH stock?
Meyka AI rates PATH with a score out of 100: 75.20 (B+) — BUY. The grade factors S&P 500 and sector comparisons, financial growth, metrics, forecasts and analyst consensus. This is informational and not investment advice.
What are the main risks for PATH stock investors?
Key risks for PATH stock include valuation sensitivity given PE 36.58, potential slowdown in enterprise IT spending, continued insider selling pressure, and execution risk as UiPath scales AI products globally.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
